Macquarie Group LTD Care Dx, Inc. Transaction History

Macquarie Group LTD

$83.5 Billion
Q3 2025

A detailed history of Macquarie Group LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 462,952 shares of CDNA stock, worth $7.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

462,952

Previous 513,767 9.89%

Holding current value

$7.38 Million

Previous $10 Million 32.95%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$11.57 - $20.63 $587,929 - $1.05 Million	-50,815 Reduced 9.89%	462,952 $6.73 Million
Q2 2025 Aug 14, 2025	SELL	$14.18 - $20.08 $681,660 - $965,285	-48,072 Reduced 8.56%	513,767 $10 Million
Q1 2025 May 15, 2025	BUY	$17.64 - $25.07 $2.13 Million - $3.02 Million	120,632 Added 27.34%	561,839 $9.97 Million
Q4 2024 Feb 14, 2025	BUY	$20.4 - $32.2 $9 Million - $14.2 Million	441,207 New	441,207 $9.45 Million
Q4 2022 Feb 21, 2023	SELL	$10.88 - $20.05 $7.83 Million - $14.4 Million	-719,373 Reduced 44.9%	882,664 $10.1 Million

Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $5.51 Million - $9.05 Million	-342,981 Reduced 17.63%	1,602,037 $27.3 Million
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $4.86 Million - $9.43 Million	237,381 Added 13.9%	1,945,018 $41.8 Million
Q1 2022 May 16, 2022	BUY	$28.19 - $46.6 $2.36 Million - $3.89 Million	83,575 Added 5.15%	1,707,637 $63.2 Million
Q4 2021 Feb 11, 2022	SELL	$41.2 - $73.6 $507,419 - $906,457	-12,316 Reduced 0.75%	1,624,062 $73.9 Million
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $11.4 Million - $17.8 Million	193,535 Added 13.41%	1,636,378 $104 Million
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $90.8 Million - $137 Million	1,440,526 Added 62172.03%	1,442,843 $132 Million
Q1 2021 May 14, 2021	BUY	$57.62 - $95.6 $4,033 - $6,692	70 Added 3.12%	2,317 $158,000
Q4 2020 Feb 16, 2021	BUY	$41.43 - $77.09 $38,115 - $70,922	920 Added 69.33%	2,247 $162,000
Q2 2020 Aug 11, 2020	BUY	$18.95 - $35.43 $25,146 - $47,015	1,327 New	1,327 $47,000
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $910,602 - $1.85 Million	-65,323 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$19.24 - $28.41 $253,698 - $374,614	-13,186 Reduced 16.8%	65,323 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $736,683 - $1.47 Million	36,779 Added 88.14%	78,509 $1.78 Million
Q2 2019 Aug 14, 2019	SELL	$25.78 - $39.77 $88,012 - $135,774	-3,414 Reduced 7.56%	41,730 $1.5 Million
Q1 2019 May 15, 2019	SELL	$22.09 - $39.21 $107,070 - $190,050	-4,847 Reduced 9.7%	45,144 $1.42 Million
Q4 2018 Feb 15, 2019	SELL	$19.89 - $30.02 $13,923 - $21,014	-700 Reduced 1.38%	49,991 $1.26 Million
Q3 2018 Nov 15, 2018	BUY	$12.1 - $28.85 $355,631 - $847,930	29,391 Added 137.99%	50,691 $1.46 Million
Q2 2018 Aug 14, 2018	SELL	$7.93 - $15.79 $457,561 - $911,083	-57,700 Reduced 73.04%	21,300 $261,000
Q1 2018 May 11, 2018	BUY	$5.18 - $7.97 $275,058 - $423,207	53,100 Added 205.02%	79,000 $630,000
Q4 2017 Feb 15, 2018	BUY	$3.98 - $7.37 $103,082 - $190,883	25,900	25,900 $190,000

Others Institutions Holding CDNA

# of Institutions

201

Shares Held

54.5M

Call Options Held

150K

Put Options Held

57.6K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $852M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Care Dx, Inc. Transaction History